Volume 18, Issue 1, Pages 61-68 (February 2011) Glatiramer acetate recovers microscopic tissue damage in patients with multiple sclerosis. A case–control diffusion imaging study R. Zivadinov, Sara Hussein, Milena Stosic, Jacqueline Durfee, Jennifer L. Cox, Diane L. Cookfair, Komal Hashmi, Nadir Abdelrahman, Neeta Garg, Michael G. Dwyer, B. Weinstock-Guttman Pathophysiology Volume 18, Issue 1, Pages 61-68 (February 2011) DOI: 10.1016/j.pathophys.2010.04.007 Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions
Fig. 1 Percent within-subject change from baseline in diffusion-weighted imaging (DWI) measures after 12 and 24 months of glatiramer acetate therapy in MS patients and healthy controls. MPD: mean parenchymal diffusivity; RRMS: relapsing–remitting multiple sclerosis; HC: healthy controls. Pathophysiology 2011 18, 61-68DOI: (10.1016/j.pathophys.2010.04.007) Copyright © 2010 Elsevier Ireland Ltd Terms and Conditions